PharmaEssentia
Overview
PharmaEssentia is a fully integrated global biopharmaceutical company that develops treatments for myeloproliferative neoplasms, hepatitis, and other diseases.
Therapeutic areas
API / Drug Master Files
PharmaEssentia holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- GEMCITABINE HYDROCHLORIDEInactive2010-10-14
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to PharmaEssentia in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
ACHN Pharmaceuticals Inc.
USA
ApoPharma Inc.
Canada
Blueprint Medicines Corporation
United States
Clementia Pharmaceuticals Inc.
Canada
Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi)
United States
Forma Therapeutics Holdings, Inc.
United States
Immedica Pharma AB
Sweden
LFB Biotechnologies S.A.
France
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.